Clinical Trial Update: Study Comparing Tigecycline and Vancomycin With Aztreonam in Complicated Skin and Skin Structure Infections [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing tigecycline to vancomycin with aztreonam for complicated skin and soft tissue infections; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Skin and Soft Tissue Infections

Drugs mentioned

• Aztreonam (Azactam) (aztreonam)
• Tigecycline (Tygacil) (tigecycline)
• Vancomycin (vancomycin)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Skin Diseases, Infectious | Phase 3 | Status: COMPLETED